Assessing the Effects of Patient Self-Rating of Voice Quality on Voice Therapy Attendance and Outcomes
1 other identifier
interventional
42
1 country
1
Brief Summary
The purpose of this study is to assess the effects of incorporating educational online modules into voice therapy. One of the main reasons that voice therapy fails is lack of participation and engagement from the patient's side. The researchers hope to learn if increasing patient engagement via educational online modules during this waiting period between evaluation and first therapy session is useful in increasing understanding of the therapeutic framework of voice therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedStudy Start
First participant enrolled
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 22, 2024
CompletedNovember 28, 2025
November 1, 2025
1.8 years
January 21, 2022
November 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change of voice handicap perception across the 3 groups
Will be measured by Voice Handicap Index -10 (VHI-10), a patient reported outcome measure used to record the patient's perception of impairment or handicap due to a voice problem. A score of over 10 is considered to be abnormal. The scores in all three groups will be compared and analyzed.
Baseline (Day 1) visit, 8 - 10 week visit
Change of Online education module acceptance across the 3 groups
Will be measured by attendance data (number of sessions recommended versus attended, number of no shows) using the standard patient data collected according to standard of care process.
Baseline Visit (Day 1), Last day of visit (up to 4 months from baseline)
Secondary Outcomes (3)
Change of perceived effectiveness of voice therapy
Baseline (Day 1) visit, 8 - 10 week visit
Change of patient's perception on voice therapy
Baseline (Day 1) visit, 8 - 10 week visit
Change of perceptual voice ratings
Baseline (Day 1) visit, 8 - 10 week visit
Study Arms (3)
Experimental Group
EXPERIMENTALParticipants will complete an online module with content focusing on patient self-rating of vocal quality within 24 hours of evaluation, approximately 1-2 weeks prior to their first therapy session, and within 24 hours after each therapy session;
Sham Control Group
SHAM COMPARATORParticipants will complete an online module within 24 hours of evaluation, approximately 1-2 weeks prior to their first therapy session, and within 24 hours after each therapy session with content focusing on vocal hygiene.
Control group
NO INTERVENTIONParticipants will not complete an online module. The groups will be compared in terms of attendance, self-efficacy, and treatment outcome measures based on the data collected within the NYU Voice Center standard of care
Interventions
The novel online module the authors developed consists of a patient education on acoustic-perceptual rating of voice quality (CAPE-V), practice rating sample recordings of others' voices, and the patient's self-rating of their own voice in real time during a standard sentence-reading task. The module also includes the Self-Efficacy Scale for Voice Therapy.
The generic online patient education module on vocal hygiene during the waiting period between their initial evaluation and their first therapy session that also includes the Self-Efficacy Scale for Voice Therapy
Eligibility Criteria
You may qualify if:
- Age \>18 years
- English-speaking
- Have access to technology, including Internet
- Diagnosed with dysphonia with a recommended treatment of voice therapy.
- Willingness to complete all clinical/research assessments
- Ability to give informed consent
You may not qualify if:
- Patients who undergo surgical intervention during the course of therapy Contraindications for participation in voice therapy
- Diagnosis of Parkinson's Disease or other neurodegenerative, progressive disorder (e.g., ALS)
- Previous training in acoustic-perceptual voice quality rating, for example a speech language pathology student
- Visual impairments that would prevent the completion of an online module.
- Those with self-reported moderate-profound hearing loss or deafness that would preclude them from participating in the study
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aaron Johnson, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2022
First Posted
February 14, 2022
Study Start
January 19, 2023
Primary Completion
October 22, 2024
Study Completion
October 22, 2024
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data.Upon reasonable request. Requests should be directed to Aaron.Johnson@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)